cellectis (ALCLS:Euronext Paris)
Martin Bitsch M.D.
Former Independent Director and Member of Compensation Committee, Cellectis S.A.
|Age||Total Calculated Compensation||This person is connected to 3 board members in 1 different organizations across 3 different industries.|
See Board Relationships
Mr. Martin Bitsch, MD serves as an Investment Manager of BI Biomedical Venture III BI BioMedical Venture IV and BankInvest BioMedical Venture. Dr. Bitsch is a co-founder of Genmab A/S (Denmark). After ten years of general practice, Dr. Bitsch joined the pharmaceutical industry by becoming Director of Clinical Investigations with Roche for Scandinavia and then for America and Europe and finally, the world. In 1996, he joined the IBAH group, firstly as director of the ...
8 rue de la Croix JarryPhone: 33 1 81 69 16 00
Paris, Ile-de-France 75013
Board Members Memberships*
Education*There is no Education data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Jeffrey R. Immelt||Executive Chairman and Chief Executive Officer|
General Electric Company
|Rakesh Sachdev||Chief Executive Officer, President and Director|
|Edward O. Lanphier II||Founder, Chief Executive Officer, President, Director and Member of Clinical Review Committee|
Sangamo Biosciences Inc.
|Richard Ridinger||Chief Executive Officer|
Lonza Group Ltd
|SFr.1.3M||Compensation as of Fiscal Year 2014.|